Protia Inc. (KOSDAQ:303360)
4,905.00
+70.00 (1.45%)
At close: Jul 21, 2026
Protia Market Cap
Protia has a market cap or net worth of 63.18 billion as of July 21, 2026. Its market cap has increased by 42.20% in one year.
Market Cap
63.18B
Enterprise Value
50.22B
Revenue
16.25B
Ranking
n/a
PE Ratio
15.73
Stock Price
4,905.00
ChartMarket Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 63.18B, a decrease of -19.43%. That is a compound annual growth rate of -2.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 63.18B | -21.38% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 210.64B |
| 3billion | 172.48B |
| GENINUS | 80.95B |
| Cytogen | 67.94B |
| GC Medical Science | 57.07B |
| Inventera | 56.48B |
| HLB Panagene | 48.62B |
| Seoulin Bioscience | 39.06B |